Aktieselskabet Schouw & Co. (SCHO) Earnings Call Transcript & Summary
November 6, 2026
Earnings Call Speaker Segments
Operator
operatorGood day, everyone, and welcome to the Schouw & Co. conference call. This is Lorenzo, the operator from Chorus Call. Just a reminder that <<operator_script>> apply, and this call is being recorded. <<operator_script>> At this point, I'm happy to turn things over to Jens Bjerg Sorensen, our CEO. Sir, the floor is yours.
Jens Sørensen
executiveThanks a lot for that introduction. And on my end as well, a very warm welcome to the call on our Q3 report. Here in the room with me is our CFO, Thomas Hansen, along with CIO Kasper Okkels, ready to assist me should any questions arise. Now let's turn to Page 2. All in all, we posted a strong quarter — an all-time high and very satisfying. Revenue rose 16% to DKK 10.6 billion, while EBITDA climbed 37% to nearly DKK 1.2 billion, giving a margin of 11.3%. Broadly speaking, we saw improvements across the entire portfolio. It is very positive to note as well that profit before tax rose 69% to DKK 881 million. We also witnessed a very satisfying trend in our financial key figures. Operating cash flow came in 8% higher at DKK 966 million. Net interest-bearing debt fell 46% to DKK 2.6 billion, clearly with a large contribution as well from the proceeds of our BioMar IPO. Leverage now stands at 0.8x EBITDA. Return on invested capital ex-goodwill rose to 15.9%, and with that we surpassed our previous target of 15%. There was also some activity in our portfolio.
Jens Sørensen
executiveStarting in September, Spectre was consolidated as the seventh portfolio company in our portfolio. I'll return to Spectre a bit later on. Broadly speaking, we're seeing a lot of activity, and our backlog is very solid, which supports raising our guidance for the full year. Now I'll move to Slide 3 and turn to BioMar. BioMar posted record-high volumes along with exceptionally strong earnings. Feed volumes rose 5% to 488,000 tonnes. In fact, growth was seen across all 3 feed segments. Revenue climbed 19% to DKK 5.8 billion. Part of that also reflected very high raw material prices. EBITDA at BioMar rose 44% to DKK 736 million. The main drivers were better margins and BioMar's strong capacity to make use of a diversified raw material base. BioMar delivered very strong earnings in the Salmon and Selected Species segments. The Shrimp segment saw very good volume development, but earnings took a hit from higher raw material energy costs, particularly in Ecuador, and also toll milling. The segment was additionally affected by a bad debt and by ramped-up costs in Costa Rica and in Vietnam of around DKK 20 million. So as we look into the Shrimp segment, we see profitability having stabilized.
Jens Sørensen
executiveBroadly speaking, there was a really solid underlying trend at BioMar, with good progress across the JVs and associated companies. Even with activity running higher, working capital came down, and BioMar's return on invested capital excluding goodwill climbed to 34.3%, which we consider quite impressive. On the back of that strong year-to-date momentum, BioMar lifted its guidance. Revenue is now projected at DKK 7.8 billion (sic) DKK 17.8 billion to DKK 18.6 billion, while EBITDA is expected in the range of DKK 1.72 billion to DKK 1.79 billion. Let me move on to GPV, Page 4. GPV posted very robust order momentum, which is fueling earnings growth. Revenue rose 9% to DKK 2.3 billion. GPV sustained its elevated level of order intake. As a matter of fact, book-to-bill now stands at 1.92, which is highly satisfying and impressive. EBITDA grew 26% to DKK 217 million. At GPV, the EBITDA margin went from 8% to 9.3%, progressing nicely toward the 10% target. GPV kept improving productivity throughout the organization and also benefited from numerous structural efficiency programs and footprint choices already made. GPV is gearing up for additional growth. Capacity is being expanded in Thailand as well as Mexico. The commercial pipeline stays very robust, and orders are now arriving from the highly interesting data center segment.
Jens Sørensen
executiveThat said, GPV is likewise feeling pressure on the supply of components — on certain components — but it has a really solid setup for handling that. GPV's outlook has been lifted. Revenue is now projected at between DKK 8.8 billion and DKK 9.2 billion, while EBITDA has been raised to a range of DKK 740 million to DKK 770 million. If we move to Page 5. HydraSpecma kept growing and showed very strong commercial momentum. Revenue rose 12%, reaching DKK 838 million. And here too, growth was recorded across the 3 divisions. Renewables and global OEM are still delivering really strongly. EBITDA climbed 11%, hitting DKK 108 million. In this case, HydraSpecma benefited from very robust supply chain optimization, along with ongoing improvements to its production footprint, and return on invested capital ex-goodwill rose to 19.5% for HydraSpecma. The company is putting investment into additional growth. We have just brought our new 22,000 square meter facility in China into operation, and it is now running at full capacity. HydraSpecma is broadening its capabilities in cooling and fluid conveyance for the data center segment. HydraSpecma as well is seeing a very strong order intake and a solid order book, which means revenue guidance is kept at DKK 3.4 billion to DKK 3.6 billion, though the EBITDA expectation has been raised to DKK 444 million (sic) DKK 445 million to DKK 465 million.
Jens Sørensen
executiveMoving on to Page #6, Borg Automotive. Profitability at Borg Automotive is on the rise even though markets remain very challenging, with revenue flat at DKK 418 million. Part of that also reflects a deliberate phaseout of unprofitable revenue, with the company really being scrutinized on that front. EBITDA rose to DKK 27 million, and we particularly saw better profitability in the Newman segment. The Refine4Future transformation plan is now genuinely delivering the productivity gains and cost optimization as expected. Working capital came down 30%, and net interest-bearing debt was reduced as a result too, which is very positive. Borg Automotive's commercial transformation strategy is continuing and showing good results. We now see the One Borg go-to-market concept launched, which means the Reman and Newman concepts are now combined. We also had good news in the market. We had what we call a remanufactured eDrive Motor that won the prestigious Innovation Award at the Automechanika Fair in Frankfurt. Guidance, of course, is narrowed. Revenue a little bit down toward the lower end, also an effect of the phaseout of unprofitable revenue. EBITDA now DKK 95 million to DKK 110 million. Then turning to Page #7. Fibertex Personal Care is delivering resilient earnings in very volatile markets. Revenue increased 21% to DKK 507 million, mainly driven by higher raw material prices.
Jens Sørensen
executiveEBITDA, though, held steady at DKK 53 million. As a matter of fact, earnings came in above expectations even with raw material volatility at such elevated levels. Our Danish operation delivered a robust performance, and the printing business likewise kept performing really strongly. Fibertex Personal Care got better at handling that volatility. They reworked their pricing mechanisms and could also draw on a diversified raw material sourcing platform. Their sharp attention to operational efficiency carried on, along with pushing innovation forward, which matters a great deal in this company. For Fibertex Personal Care, the market picture is still mixed. European demand is anticipated to stay stable, while in Asia, as before, overcapacity and pricing pressure persist in that region. Guidance means revenue expectations stay as they were, though EBITDA has been lifted to a range of DKK 170 million to DKK 190 million. Moving to Page #8. This brings us to Fibertex Nonwovens. Fibertex Nonwovens genuinely delivered strong growth and earnings, and that company keeps improving. Sales volumes rose 5%. Revenue climbed 22% to DKK 678 million, a combination of raw material prices and product mix, with growth across a number of key segments and markets. At Fibertex Nonwovens, EBITDA rose 69% to DKK 88 million. Greater activity and operational enhancements are the main drivers, along with a very solid gain in profitability in the highly important U.S.
Jens Sørensen
executiveTurning to the market. FIN represents a commercial development effort that is quite broad in scope. Our product and project pipeline is robust, with expansion in the wipes and hygiene segments, primarily across the U.S. and Europe. And, as I mentioned, the pipeline looks very appealing, particularly in what we refer to as high-value segments. FIN Nonwovens lifted their guidance. Both revenue and EBITDA went up. For that company, revenue is now projected at DKK 2.6 billion to DKK 2.7 billion, while EBITDA is now projected at DKK 280 million to DKK 300 million. Moving then to Page 9 and the final company in our portfolio — not the least important, but the newest addition — Spectre is now part of Schouw & Company. We are showing only 1 month of activity with Spectre. It was consolidated into Schouw & Co starting in September, and revenue came in at DKK 57 million. Turnover at Spectre has seasonal peaks, and September is typically rather low. EBITDA was affected by acquisition accounting. EBITDA for the month was negative DKK 10 million, yet the underlying EBITDA on the turnover is positive. As a matter of fact, Spectre saw a DKK 14 million negative impact stemming from nonrecurring and noncash PPA issues or items. Spectre possesses a very strong platform for further growth. The order book now stands 21% above last year.
Jens Sørensen
executiveDuring Q3, Spectre opened a fourth factory in Vietnam. That plant is the most automated one the company has, and expectations for it are big. They also rolled out an ERP system across the whole group. The outlook for 2026 rests on just 4 months of activity. Revenue is DKK 300 million to DKK 400 million, and EBITDA after acquisition-related costs is expected to land around 0. As has been said before, the longer-term outlook for Spectre is promising, with organic growth anticipated and a 2030 ambition of DKK 1.7 billion to DKK 2.0 billion in revenue, with EBITDA in the range of 15% to 17%. Moving then to Page #10, a quick wrap-up of our full year guidance. Full year guidance was raised on the back of very strong performance through the first 9 months, broad-based earnings across the entire portfolio, and also high order intake and solid order books in several businesses, which really gives good comfort for the guidance, meaning turnover is now expected to be DKK 36.2 billion to DKK 38.1 billion and EBITDA now DKK 3.37 billion to DKK 3.52 billion. And we also expect to be able to deliver profit before tax above the DKK 2 billion mark. So with that guidance update, I will open up for questions.
Operator
operatorOur first question is from Claus Almer at Nordea.
Claus Almer
analystTo start with, Jens, well done on yet another set of very, very strong results in Q3. I have a handful of questions, and I'll go through them one at a time. The first is a broader top-down one. After Q2 we saw guidance raised across a very wide front, and now in Q3 there are again a number of upgrades. Does this latest upgrade mostly reflect caution on your part? Or would you say you're largely surprised by how strong demand dynamics have been? That's the first one.
Jens Sørensen
executiveYes. Thanks for that, Claus, and thanks as well for your comments. No, broadly speaking, as I mentioned, we always provide guidance based on what we observe and have confidence in. And I have to say it doesn't come as a great surprise, though we are taken aback that things are going so smoothly. We're truly seeing the impact now of all the efficiency gains we've made and our strong market position. And beyond that, we're gaining traction in appealing new segments such as data segments, defense, and so on. So it's positive for all of us to have such a strong quarter. But it really demonstrates that the platform beneath us may be even more robust than we had assumed.
Claus Almer
analystAll right, and the next question is about GPV. Could you update us on how well you're able to source the different components, and especially on the lead times for those?
Jens Sørensen
executiveYeah. That’s a really interesting question, because of course — not to call it a problem — it’s always something we’re watching, and we’re seeing these longer lead times. We’ve set up a dedicated task force to deal with this, and we’ve also decided we’re going to build up more inventory, which also means net working capital and those things will be higher, but we need to be able to supply. We have many years of experience in that, and so far we’re doing quite well, but we’ve really put a lot of resources and effort into that area because it’s so important for us.
Claus Almer
analystHowever, the report mentions that visibility remains limited, yet your book-to-bill keeps climbing higher and higher. So does that mean you're receiving the orders but aren't 100% certain when you'll be able to deliver them? And if that's the situation, might we see some penalties if there are delays?
Jens Sørensen
executiveThat's a very relevant question too, Claus. You could argue that some customers might be placing larger orders than needed out of worry about supply availability, and so forth. Even so, at this point we have confidence in an extremely robust order book, and up to now we haven't run into any constraints on supply or on deliveries. Typically, we maintain a solid balance with our customers and so on. As you'll recall, several years ago we also put in place this purchase price variance system, under which we source these complicated components — not at just any price, but at the price — and then we pass that along to our customers. So thus far, no issues, knocking on wood, and we're in a good position. Naturally, though, we do need to stay concerned.
Claus Almer
analystAll right, and Jens, I won’t let you down. So I’ll just say great job on the net working capital performance for the quarter.
Operator
operatorOur next question is from Ulrik Bak at Danske Bank.
Ulrik Bak
analystI'll go through them one at a time too. So to follow up on GPV: clearly, you mentioned strong demand and strong order intake, but also those worries about component scarcity. And then during the quarter, we saw a pretty nice margin uplift. But if these component scarcity challenges perhaps intensify, as you may see, could there potentially be a hit to the EBITDA margin going forward? Or how do you go about mitigating that?
Jens Sørensen
executiveThat isn't what we anticipate, and we do have pretty powerful pass-through mechanisms and so forth. But we don't anticipate that in any way. And the improvement in our margin really stems from many different elements, but chiefly also internal productivity, our footprint shutting factories and relocating. So it's quite a robust margin improvement that we're seeing. And as I mentioned as well, we expect to be able to hit the 10% target. So I feel quite at ease with how the margin has been raised -- delivered. Naturally, we need to and must keep our eyes very, very closely on price increases and so forth, on components. But up to now, that isn't a worry.
Ulrik Bak
analystGood to hear that. Next, a question about Borg Automotive. During Q3, growth was down somewhat. The implied guidance for Q4 points to modest growth as well — essentially flat at the midpoint, roughly there. Are you making adjustments in case the top line drops further after Q4? Or are there initiatives you've put in place to boost sales? And how does that line up with the efficiency program you're also running to take out cost?
Jens Sørensen
executiveNo. We aren't getting ready for additional top-line cuts. As a matter of fact, we're refining how we go to market and genuinely anticipate gaining share as well. There's a great deal of turbulence out there, and as one of the larger players, we're standing fairly strong. With the new approach, the One Borg go-to-market, we now have a completely new sales organization in place. So we truly expect to keep pushing forward. And even in a very tough market, we're seeing that we're establishing a market position and market share. So we're preparing to keep growing and also expect that—without revealing too much—into 2027. But I think when we introduced our Refine4Future plan, we also stated that we anticipate a substantial uplift from it. So we expect to drive profit uplift in '27 as well.
Ulrik Bak
analystGot it — let's move to the question about Fibertex Nonwovens. You saw a solid year-over-year increase in earnings. My guess is that raw material effects account for part of that, and possibly FX as well. Could you strip those out and then elaborate on the underlying earnings growth, the volume growth, and so on?
Jens Sørensen
executiveYes. It's clear that, as you're also aware—since you've been tracking us for quite a while—we had many problems in the U.S. with new facilities and so forth. That is now genuinely generating profit. So we're seeing a very large profit increase in the U.S. We're seeing a significantly improved product mix, where—with new lines and added capacity and so on—we have a lot of what we refer to as filler volume, and that filler volume carries a low margin and so forth; we are moving away from it. So the product mix is considerably better. Efficiency in the U.S. has improved substantially. And then, more broadly, we've also seen a volume increase that contributes to the margin as well. So that reflects the effect of many factors, including internal ones we've worked hard on.
Ulrik Bak
analystGot it. My last question is about the buyback. From what I can tell, you've already used up the amount that was planned under the current buyback, even though it runs until the end of the year. Yet you haven't announced another buyback or an increase to the current one. Could you elaborate on the reasoning behind that, because it might fuel speculation about further M&A opportunities or something along those lines. So some color would be great.
Jens Sørensen
executiveYes. Thanks. I believe we should let Kasper Okkels try to expand on that.
Kasper Okkels
executiveThat's correct, Ulrik. If you consider how much of the existing program has already been carried out, then the amount set aside for share buyback has been more or less used up. No decision has been made yet on whether any further allocation for share buybacks will be made. That said, as we stated at the Capital Markets Day, share buyback ranks as a priority for us, and in the present environment we also think it is a good time to repurchase shares.
Operator
operator<<operator_script>> Our following question is from Emil Haargaard at DNB Carnegie.
Emil Haargaard
analystMost of what I wanted to ask has been covered already, so I have just a few remaining. Let me also offer my congratulations on another strong Q3 across all companies — nicely done. My first question concerns GPV and the book-to-bill ratio in Q3. Could you perhaps break down how much of that robust book-to-bill ratio comes from new customer wins as opposed to existing customers placing new orders? And how should we view the conversion of this order intake? Will it mainly land in '28, or might some of it already contribute in '27? That's my first question.
Jens Sørensen
executiveThank you so much, Emil. My take is that a significant portion of that order intake is going to come through in 2027. Naturally, we also have a longer horizon in play, but the backlog we're carrying into 2027 is very, very solid. As for how that order intake breaks down, we're also seeing new customers join. In fact, within the data center segment, GPV received its largest order ever from a single customer, and it's very encouraging to see such a substantial order uptake in that segment. Beyond that, our existing accounts — what we refer to as AAA and AA customers, or the bigger customers — are genuinely improving and placing stronger orders. So overall, we're seeing solid order intake across the board, along with new customers coming in. And I'd add that, as a result of the really strong global footprint GPV now has, we're seeing effects from that as well.
Emil Haargaard
analystGreat. And as for my final question, on the new facility in China, how should we think about capacity utilization ramping up? How fast do you expect that capacity to be filled?
Jens Sørensen
executiveThat's a very fair question. And of course, Emil, this is also a project-driven business. Naturally, we've built capacity for the future as well, but we're seeing activity pick up considerably, and we also have some footprint decisions ahead — we'll be shifting production into China from other facilities within the footprint. So we've put a great deal of effort into securing as much volume as we can for that facility, given its efficiency and solid margins and so on. But we've also built it so that it can handle future growth.
Operator
operatorOur next question is from Yiwei Zhou of SEB.
Yiwei Zhou
analystThis is Yiwei from SEB, and I have one question remaining. Turning to the robust order book at GPV and HydraSpecma — I appreciate what you said about demand from the data center and renewable energy sectors. What I'm trying to get at, though, is whether any inventory build-up is happening on your customers' side, driven by worries over component shortages or cost inflation. I'd just like to understand whether a timing effect is at play here, or whether we could see the market reverse later on.
Jens Sørensen
executiveThank you for asking that. We haven't accumulated any inventory. Naturally, we're careful about making sure our supply chain is able to fulfill the order book. So of course we've also placed orders with our suppliers and so on. But no inventory has been built up as of yet, and we likewise manage our inventory build and net working capital and such very prudently. So I believe nothing out of the ordinary stands out to us. That said, as I also said regarding GPV, we've additionally made the decision that should it be necessary, we will build inventory on a few special components provided we can truly obtain them at attractive prices. That, then, is the strategy.
Yiwei Zhou
analystNo, right — what I'm getting at is whether you're seeing inventory piling up on your customer's end.
Jens Sørensen
executiveMy apologies — I got that wrong.
Yiwei Zhou
analystMy question concerns how strong that market demand really is in terms of quality.
Jens Sørensen
executiveRight, we aren’t seeing any inventory build-up at the customer. And I’d also say the orders are solid, and we expect to deliver them. And if we look at the market, we already have orders for projects that are already sold and are in the pipeline and being built, and so on. So yes, we expect no reductions in that.
Operator
operatorOur next follow-up comes from Claus Almer, who is on the line from Nordea.
Claus Almer
analystJens, I've got just 2 follow-ups for you. The first concerns what you said about GPV and the book-to-bill — that a lot of those orders will land in '27. Yet with an order to build of almost 2x, that sounds like pretty impressive growth we ought to see in '27. So maybe — I realize you aren't giving guidance for '27 at this point — perhaps you could add a little color to that remark you made.
Jens Sørensen
executiveRight. No — like I mentioned, a large order book for GPV isn’t anything out of the ordinary, since orders and such take a very long time to develop. So we consistently see a strong order book, and I noted that a good portion of it also extends into 2028, though we have good visibility for 2027 and expect growth as well; the order book, however, doesn’t only reflect 2027. Still, it’s obviously very encouraging that those orders are already in the book. So yes.
Claus Almer
analystCould you provide that same figure going back 12 months at once? I don't remember you giving that number in Q3 '25, or perhaps just at the end of '25, so we can try to work out how this book-to-bill has trended over the years.
Jens Sørensen
executiveHonestly, I don't have that figure right in front of me, so perhaps we should circle back on it afterward, since I'd like to give you an accurate answer as well. It isn't available to me here.
Claus Almer
analystAlright, and then the last question. On Personal Care, you mentioned that your pricing mechanism has been getting better. Do you still expect some remaining effect from the price increases you've put through — meaning a bit more improvement in margin?
Jens Sørensen
executiveWe don't. There's also a minor impact from that as we raise our guidance, but we're back. We put that in place and it worked really well, since things were so volatile. So we moved from a quarterly pass-on to a monthly one, and at this point we're gradually returning to a quarterly pass-on mechanism. So I really don't anticipate any effect from that.
Operator
operatorLadies and gentlemen, that brings us to the end of the Q&A. At this point, I'd like to hand the conference back to Jens Bjerg Sorensen so he can offer any closing remarks.
Jens Sørensen
executiveMuch appreciated, and thanks for tuning in. I appreciate every one of the questions, and I hope each of you has a great weekend. That's all from Schouw & Company — goodbye.
Operator
operatorLadies and gentlemen, that brings us to the end of the conference. We appreciate your choosing Chorus Call, and thanks for taking part in the conference. You can disconnect your lines at this point. Goodbye.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Aktieselskabet Schouw & Co. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Aktieselskabet Schouw & Co. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Aktieselskabet Schouw & Co. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.